(2026). The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity. Molecular Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"The PI3Kδ Inhibitor Roginolisib (IOA‐244) Preserves T‐cell Function and Activity."
Molecular Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"The PI3Kδ Inhibitor Roginolisib (IOA‐244) Preserves T‐cell Function and Activity."
Molecular Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.